The Legal 500: Pharmaceutical Advertising Comparative Guide 2022

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

Read our overview of Pharmaceutical Advertising laws and regulations applicable in:

Read the French chapter here
Read the German chapter here
Read the UK chapter here

Latest insights

More Insights
featured image

The Commission’s Quick Fix? Freezing Additional ESRS Requirements for CSRD First-Wave Undertakings

6 minutes Jun 19 2025

Read More
Curiosity line pink background

From sales to sanctions: Optus faces $100 million penalty for unconscionable sales practices

Jun 19 2025

Read More
featured image

Dutch Court Backs The Hague’s Fossil Fuels Ad Ban

5 minutes Jun 18 2025

Read More